(Q36765445)

16 August 2017

1 reference

title

A suspenseful game of 'hide and seek' between virus and host (English)

1 reference

16 August 2017

Michael B A Oldstone

1

1 reference

PubMed ID

17375090

16 August 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

8

1 reference

16 August 2017

325-327

1 reference

16 August 2017

4

1 reference

EPIDEMIOLOGY OF LYMPHOCYTIC CHORIOMENINGITIS IN A MOUSE STOCK OBSERVED FOR FOUR YEARS

16 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-a

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Requirement for Θ-Bearing Cells in Lymphocytic Choriomeningitis Virus-induced Central Nervous System Disease

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Immunological memory and protective immunity: understanding their relation

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 6. IMMUNITY CONFERRED ON TOLERANT MICE BY IMMUNE SERUM AND BY GRAFTS OF HOMOLOGOUS LYMPHOID CELLS

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Defining parameters for successful immunocytotherapy of persistent viral infection.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Organ-specific selection of viral variants during chronic infection

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-).

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Interleukin-10 determines viral clearance or persistence in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Resolution of a chronic viral infection after interleukin-10 receptor blockade

1 reference

https://api.crossref.org/works/10.1038%2FNI0407-325

7 January 2021

Identifiers

DOI

10.1038/NI0407-325

1 reference

16 August 2017

1 reference

PubMed ID

17375090